Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

FibroGen

Biotech & Life Sciences · San Francisco, United States · Founded 1993 · IPO 2014 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$88M
Market cap · Jan/2026
Revenue
$6.4M
Latest reported FY

Investors

11 investors on FibroGen's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 11 investors entered at this stage
Brookside Capital
Astellas Pharma
Daiwa Securities Group
Bain Capital
The Rosewood Corporation
BioFund Management
Sigma Capital Group
Apothecary Capital
Merlin Biomed
Goldman Sachs
Adage Capital

Global footprint

Where FibroGen has talent and traffic

Web traffic by country
3.6K monthly visits
across markets
🇺🇸 United States69.4%
🇯🇵 Japan27.8%
Top 2 markets shown

See FibroGen on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo